Assessment of shikonin for potential estrogenic activity by dual-luciferase reporter based bioluminescent measurements in vitro

被引:2
作者
Zhang, Yi [2 ,3 ]
Li, Ping-Ping [1 ]
机构
[1] Peking Univ, Dept Integrated Tradit Chinese & Western Med, Key Lab Carcinogenesis & Translat Res,Minist Educ, Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100142, Peoples R China
[2] Beijing Univ Chinese Med, Dept Anat, Sch Preclin Med, Beijing, Peoples R China
[3] Peking Univ, Dept Integrated Tradit Chinese & Western Med, Sch Basic Med Sci, Beijing 100142, Peoples R China
来源
PHARMAZIE | 2011年 / 66卷 / 02期
关键词
STEROID SULFATASE GENES; LITHOSPERMUM-ERYTHRORHIZON; CELLS; PHARMACOLOGY; ACTIVATION; MECHANISMS; EXPRESSION; EXTRACT; CANCER;
D O I
10.1691/ph.2011.0714
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Shikonin, an active component of Lithospermum erythrorhizon Sieb. et Zucc., shows multiple pharmacological properties. However, the estrogenic activity of shikonin is remaining unclear. We assessed the potential estrogenic activity of shikonin with dual-luciferase reporter assay and bioluminescent measurements, by using transient cotransfection with estrogen dependent plasmid pERE-TK-Luc and internal control plasmid pRL-TK in MCF-7 cells. Estrogenic activity of shikonin, even at high concentration did not alter significantly compared to negative control (p > 0.05) and were significantly lower than those with E-2 (p < 0.01). Concluding, shikonin demonstrates no estrogenic activity in vitro.
引用
收藏
页码:141 / 143
页数:3
相关论文
共 16 条
[1]   Cellular pharmacology studies of shikonin derivatives [J].
Chen, X ;
Yang, L ;
Oppenheim, JJ ;
Howard, OMZ .
PHYTOTHERAPY RESEARCH, 2002, 16 (03) :199-209
[2]   Metabolic activation promotes estrogenic activity of the phytoestrogen-rich plant [J].
Cherdshewasart, Wichai ;
Sriwatcharakul, Suttijit .
MATURITAS, 2008, 59 (02) :128-136
[3]   Dual role of shikonin in early and late stages of collagen type II arthritis [J].
Dai, Qiaomei ;
Fang, Jianghong ;
Zhang, Feng-shan .
MOLECULAR BIOLOGY REPORTS, 2009, 36 (06) :1597-1604
[4]   Estrogenic activity of a polyphenolic extract of the leaves of Epimedium brevicornum [J].
De Naeyer, A ;
Pocock, V ;
Milligan, S ;
De Keukeleire, D .
FITOTERAPIA, 2005, 76 (01) :35-40
[5]   Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens [J].
Gutendorf, B ;
Westendorf, J .
TOXICOLOGY, 2001, 166 (1-2) :79-89
[6]   The multifaceted mechanisms of estradiol and estrogen receptor signaling [J].
Hall, JM ;
Couse, JF ;
Korach, KS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) :36869-36872
[7]  
HENDERSON BE, 1988, CANCER RES, V48, P246
[8]   Estrogen: Physiology, pharmacology, and formulations for replacement therapy [J].
Ruggiero, RJ ;
Likis, FE .
JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2002, 47 (03) :130-138
[9]   Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells [J].
Singh, F ;
Gao, DY ;
Lebwohl, MG ;
Wei, HC .
CANCER LETTERS, 2003, 200 (02) :115-121
[10]   Estrogenic activity of the dichloromethane extract from Pueraria mirifica [J].
Sookvanichsilp, N. ;
Soonthornchareonnon, N. ;
Boonleang, C. .
FITOTERAPIA, 2008, 79 (7-8) :509-514